Introduction
Oculocutaneous albinism (OCA)' is a group of severe autosomal recessive disorders of pigmentation characterized by reduced or absent melanin in pigment cells of the skin, hair follicle, and eye (reviewed in references 1, 2). Type I OCA results from deficient activity of melanocyte tyrosinase (monophenol, L-dopa:oxygen oxidoreductase, EC 1. 14.18. 1), a copper-containing enzyme that catalyzes the first two steps in the melanin biosynthetic pathway: the hydroxylation of tyrosine to dihydroxyphenylalanine (dopa) and the subsequent oxidation of dopa to dopaquinone. Recently, several mutations of the tyrosinase gene have been identified in patients with typical type I OCA (3) (4) (5) (6) (7) .
We have described a novel type I OCA phenotype in which the distribution ofmelanin is correlated with local body temperature. Tyrosinase extracted from scalp and leg hairbulbs of the proband appeared to be thermosensitive, with significant loss of activity at temperatures above 35°C (8) . In this report we describe a missense substitution at codon 422 of the tyrosinase gene in this individual, and show that this mutation is specifically associated with the peripheral pigmentation phenotype in her family. Introduction of the codon 422 substitution into normal human tyrosinase cDNA results in thermosensitivity of the tyrosinase enzymatic activity expressed in transfected HeLa cells. These findings demonstrate that the codon 422 mutation is associated with a temperature-sensitive form of tyrosinase. The phenotype of temperature-related albino pigmentation in this family thus appears to be a human homologue to that in other mammals with apparent temperaturesensitive forms of tyrosinase, including the Siamese cat and the Himalayan mouse and rabbit (reviewed in 9, 10).
Methods
Clinical summary. The proband (individual 11.1 in Fig. 1 After puberty, however, they developed a unique pattern of pigmentation: relatively warm body parts (eyes, skin, hair ofthe scalp and axilla) remained unpigmented, but less warm parts (facial and pubic hair) developed slight pigmentation and relatively cool parts (arm and leg hair) became well pigmented (8) .
Polymerase chain reaction (PCR) and DNA sequience determination. Genomic DNA was isolated from peripheral blood leukocytes ( 11) of the proband and family members shown in Fig. 1 . PCR primers designed to amplify each of the five exons of the tyrosinase gene plus adjacent flanking noncoding sequences were derived from the normal human tyrosinase genomic DNA sequence (12, 13) . Each exon was amplified independently from 0.1 g of genomic DNA of the proband by 40 cycles of PCR (14) using 20-mer oligonucleotide primers P1 -P 0 (Table I) and Taq DNA polymerase (Perkin-Elmer Cetus, Norwalk, CT) exactly as described (7) . Each cycle consisted of 30 s at 94°C, I min at 50°C, and 2 min at 72°C. The amplified PCR products were purified by electrophoresis in 4% polyacrylamide gels and cloned in bacteriophage vectors M 1 3mp 1 8 or mp 19. The nucleotide sequences ofat least six independent clones per exon were determined (15) .
Restriction enzyme cleavage analysis. Fragments containing a part of the tyrosinase gene exon 1 and the complete exon 4 were amplified by PCR as described above from 0. digests were analyzed by gel electrophoresis for the presence of the codon 81 and codon 422 mutations, respectively. In vitro mutagenesis. The codon 422 CGG (Arg) CAG (Gln) mutation was introduced into the human tyrosinase cDNA expression plasmid pcTYR (16) as described (17) . Exon 4 of the tyrosinase gene was PCR amplified from DNA of an M 13 exon 4 clone containing the codon 422 mutation using oligonucleotide primer pair P1 3-P14 (Table  I) , derived from the 5' and 3' ends ofexon 4, respectively. An exon 2-3-4 product was then amplified from 30 ng of tyrosinase cDNA using as one primer 5 pmol of the purified mutant exon 4 PCR product and as second primer an oligonucleotide P 15 (Table I) (22) .
Fluorometric assay of tyrosinase activity was as described (20) except that 4 mM ascorbic acid was included in the reaction mixture as reductant for tyrosine hydroxylation (21) and to reduce any dopaquinone formed by tyrosinase back to dopa; measurement of dopa therefore provided a true estimate of the tyrosine hydroxylase activity of tyrosinase. The 55 IAI reactions containing 0.1 mM L-tyrosine, 5 AM L-dopa,4 mM ascorbic acid, 40 mM Na-phosphate buffer, pH 6.8, and 15 Al cell extract were incubated for 4 h. Production ofdopa was measured by specific fluorescence at 360 nm excitation and 490 nm emission wavelengths. One unit of tyrosinase activity was defined as 1 pmol dopa formed/min. The tyrosinase specific activities shown in Table II were corrected for slight plate to plate variation in transfection efficiency by dividing by the CAT activity (percent '4C-chloramphenicol converted to the three forms of acetyl-chloramphenicol; reference 19) in each extract.
Tyrosinase enzymatic activities were determined at both 31 and 37°C. Activity of the codon 422 mutant tyrosinase, produced in HeLa cells transfected and cultured at 31°C, was not decreased by assay at 37°C versus assay at 31VC (data not shown). Because the optimal temperature of the tyrosinase assay is 37°C (20) , only data for tyrosinase assays at that temperature are shown in Table II .
Results
Identification of the tyrosinase gene codon 422 mutation. To define the molecular basis of the temperature-related type I OCA phenotype, we sequenced PCR fragments amplified from the tyrosinase genes ofthe proband. The proband was homozygous at two nonpathologic polymorphisms; codon 192 TAT (Tyr; reference 23) and 402 CGA (Arg; reference 24). However, nucleotide sequence analyses also detected two pathologic missense substitutions in her tyrosinase coding regions. One (data not shown) was the previously-described CCT (Pro) --CTT (Leu) substitution at codon 81 (in exon 1) that is a frequent tyrosinase-negative (type IA) OCA allele in this kindred and in the Caucasian population (4). The other (Fig. 2) was a novel substitution within codon 422 (in exon 4), CGG (Arg) --CAG (Gln). The codon 422 mutation is specifically associated with these patients' temperature-related pattern of pigmentation.
The codon 81 and codon 422 substitutions both abolish restriction sites; the codon 81 mutation destroys an Hae III site (27) at codon 420 (His --Arg), only two amino acids away from the human codon 422 substitution described here. These two human and mouse tyrosinase substitutions both occur within a very highly conserved segment of the protein, and it is very likely that they result in analogous defects in structural stability of the corresponding tyrosinase polypeptides. 
